Results 241 to 250 of about 9,630,957 (406)
Endoscopic Pancreatocholangiography in the Evaluation of Pancreatic and Biliary Disease
Kazuei Ogoshi+3 more
openalex +1 more source
Amylase assay and diagnosis of pancreatic disease. [PDF]
John Lott, E C Ellison
openalex +1 more source
Traditional Chinese Medicine (TCM), while holistic and historically esteemed, faces challenges in “miracle cures” due to slow onset, long cycles, and difficulty controlling quality. This study obtains the active ingredients, glabridin (GLA) and puerarin (PUE), from Ge‐Gen Decoction (GGD), developing a safe and effective drug delivery system, GLA‐PUE ...
Jianhong Qi+7 more
wiley +1 more source
Optimal glycated hemoglobin A1c value for prediabetes and diabetes in patients with pancreatic diseases. [PDF]
Chen G+5 more
europepmc +1 more source
An embedded bioprinting enabled‐arrayed patient‐derived organoids (Eba‐PDO) platform that replicates intrinsic and extrinsic tumor characteristics is introduced. Eba‐PDOs more accurately mimic tissue than standard PDOs (Std‐PDOs) due to maturation in the tumor microenvironment.
Jonghyeuk Han+15 more
wiley +1 more source
Pancreatic amylase in serum for differential diagnosis of acute pancreatitis and acute abdominal diseases. [PDF]
G.V. Melzi d’Eril+2 more
openalex +1 more source
A GRP78 nanobody‐directed immunotoxin suppresses cancer progression and metastasis by enhancing antitumor immunity via STING pathway activation, offering a pan‐cancer‐targeted approach and immunotherapy combination strategy. Abstract The lack of targetable antigens poses a significant challenge in developing effective cancer‐targeted therapies.
Huifang Wang+16 more
wiley +1 more source
Integrated Physiology of the Exocrine and Endocrine Compartments in Pancreatic Diseases: Workshop Proceedings. [PDF]
Mastracci TL+33 more
europepmc +1 more source
Hyperbilirubinemia in Inflammatory Pancreatic Disease
Edward L. Bradley, Atef A. Salam
openalex +2 more sources
Prospective comparison of three non-invasive tests for pancreatic disease. [PDF]
I Cobden+5 more
openalex +1 more source